erdosteine has been researched along with Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, DS; Bhatia, J; Malik, S; Mutneja, E; Ray, R; Sahu, AK; Verma, VK | 1 |
| Erdogan, H; Fadillioglu, E; Sogut, S; Yilmaz, HR | 1 |
2 other study(ies) available for erdosteine and Cardiomyopathies
| Article | Year |
|---|---|
Erdosteine salvages cardiac necrosis: Novel effect through modulation of MAPK and Nrf-2/HO-1 pathway.
Topics: Animals; Biomarkers; Cardiomyopathies; Cytokines; Dose-Response Relationship, Drug; Heme Oxygenase (Decyclizing); Inflammation Mediators; Isoproterenol; Male; MAP Kinase Signaling System; Necrosis; NF-E2-Related Factor 2; Rats; Signal Transduction; Thioglycolates; Thiophenes | 2020 |
The activities of tissue xanthine oxidase and adenosine deaminase and the levels of hydroxyproline and nitric oxide in rat hearts subjected to doxorubicin: protective effect of erdosteine.
Topics: Adenosine Deaminase; Animals; Antibiotics, Antineoplastic; Antioxidants; Cardiomyopathies; Doxorubicin; Hydroxyproline; Male; Nitric Oxide; Random Allocation; Rats; Rats, Sprague-Dawley; Thioglycolates; Thiophenes; Xanthine Oxidase | 2003 |